




Healthcare Industry News: CareFusion
News Release - February 17, 2020
West Elects New Director to the Board
EXTON, Pa., Feb. 17, 2020 -- (Healthcare Sales & Marketing Network) -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's Board of Directors has elected Robert Friel as its newest member. With the addition of Mr. Friel, West's Board of Directors increases in size to 11 directors."We welcome Robert Friel to West's Board of Directors," said Patrick J. Zenner, Chair of the Board of Directors, West. "Rob's extensive experience serving as both the Chairman and CEO of a global business focused on improving human health is well-aligned with West's mission and with the pharmaceutical and medical device customers our Company serves. With his significant board and industry experience, we know Rob will be a valuable addition to West's Board of Directors and look forward to working with him."
About West
West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2019 net sales of $1.84 billion reflect the daily use of more than 100 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world.
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
Source: West Pharmaceutical Services
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.